International Journal of Epidemiology 2003;32:1-22
© International Epidemiological Association 2003
30TH THOMAS FRANCIS JR MEMORIAL LECTURE |
‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease?*
University of Bristol, Department of Social Medicine, Canynge Hall, Whiteladies Road, Bristol BS8 2PR, UK.
Abstract
Associations between modifiable exposures and disease seen in observational epidemiology are sometimes confounded and thus misleading, despite our best efforts to improve the design and analysis of studies. Mendelian randomization—the random assortment of genes from parents to offspring that occurs during gamete formation and conception—provides one method for assessing the causal nature of some environmental exposures. The association between a disease and a polymorphism that mimics the biological link between a proposed exposure and disease is not generally susceptible to the reverse causation or confounding that may distort interpretations of conventional observational studies. Several examples where the phenotypic effects of polymorphisms are well documented provide encouraging evidence of the explanatory power of Mendelian randomization and are described. The limitations of the approach include confounding by polymorphisms in linkage disequilibrium with the polymorphism under study, that polymorphisms may have several phenotypic effects associated with disease, the lack of suitable polymorphisms for studying modifiable exposures of interest, and canalization—the buffering of the effects of genetic variation during development. Nevertheless, Mendelian randomization provides new opportunities to test causality and demonstrates how investment in the human genome project may contribute to understanding and preventing the adverse effects on human health of modifiable exposures.
Genetic epidemiology—the theme of this issue of the International Journal of Epidemiology—is seen by many to be the only future for epidemiology, perhaps reflecting a growing awareness of the limitations of observational epidemiology1 (Box 1). Genetic epidemiology is concerned with understanding heritable aspects of disease risk, individual susceptibility to disease, and ultimately with contributing to a comprehensive molecular understanding of pathogenesis. The massive investment and expansion of human genetics, if it is to return value for the common good, must be integrated into public health functions. The human genome epidemiology network (HuGE Net—http://www.cdc.gov/genetics/huge.htm) has been established to promote the use of genetic knowledge—in terms of genetic tests and services—for disease prevention and health promotion.2,3 A broad taxonomy of human genome studies of public health relevance has been developed4 (Box 2). In this issue of the IJE, we publish a paper by Miguel Porta,5 who highlights the need for a more rational approach to genetic testing, given the likely low penetrance of many genes associated with cancers,6 likening the role of the genome to a jazz score that is interpreted and developed through experience and context—and is seldom predictable. Such insights may well temper enthusiasm for genetic testing in populations. However, in parallel to the approaches advocated by HuGE, genetic epidemiology can lead to a more robust understanding of environmental determinants of disease (e.g. dietary factors, occupational exposures, and health-related behaviours) relevant to whole populations (and not simply to genetically susceptible sub-populations).7–10 This approach has recently been referred to as ‘Mendelian randomization’.11–15 Here we begin by briefly reviewing reasons for current concerns about aetiological findings generated by conventional observational epidemiology and then we outline the potential contribution (and limitations) of Mendelian randomization.
| Box 1 Nature announces a genetic epidemiology initiative alongside a cartoon illustrating the demise of classical epidemiology. ‘Epidemiology set to get fast-track treatment’ ‘A consortium of leading European research centres and pharmaceutical companies will this week announce a plan to transform epidemiology by combining it with the new techniques of high-throughput biology. They plan to create a new field of study—genomic epidemiology—by using screening technologies derived from the human genome project ... We think it is important to expand classical epidemiology and genetic epidemiology to take it to this high-throughput mode, says Esper Boel, vice-president of biotechnology research at Novo Nordisk. We want to use post-genomic technologies to create a new clinical science, to turn functional genomics into real clinical chemistry.’ From: Butler D. Epidemiology set to get fast-track treatment. Nature 2001;414:139. Reprinted with permission.
|
| Box 2 A taxonomy of genetic studies of public health relevance Surveillance
Aetiology
Health services research
Adapted from Khoury MJ, Burke W, Thomson EJ (eds). Genetics and Public Health in the 21st Century. Oxford: Oxford University Press, 2000.
|
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  T. M Palmer, J. R Thompson, M. D Tobin, N. A Sheehan, and P. R Burton Adjusting for bias and unmeasured confounding in Mendelian randomization studies with binary responses Int. J. Epidemiol., May 7, 2008; (2008) dyn080v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R. Folsom, J. S. Pankow, J. M. Peacock, S. J. Bielinski, G. Heiss, and E. Boerwinkle Variation in TCF7L2 and Increased Risk of Colon Cancer: The Atherosclerosis Risk in Communities (ARIC) Study Diabetes Care, May 1, 2008; 31(5): 905 - 909. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Freathy, N. J. Timpson, D. A. Lawlor, A. Pouta, Y. Ben-Shlomo, A. Ruokonen, S. Ebrahim, B. Shields, E. Zeggini, M. N. Weedon, et al. Common Variation in the FTO Gene Alters Diabetes-Related Metabolic Traits to the Extent Expected Given Its Effect on BMI Diabetes, May 1, 2008; 57(5): 1419 - 1426. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Bochud, A. Chiolero, R. C Elston, and F. Paccaud A cautionary note on the use of Mendelian randomization to infer causation in observational epidemiology Int. J. Epidemiol., April 1, 2008; 37(2): 414 - 416. [Full Text] [PDF]
|
|
|
|
|
|
G. D. Smith and S. Ebrahim Reply Int. J. Epidemiol., April 1, 2008; 37(2): 416 - 417. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Boccia, R. Hung, G. Ricciardi, F. Gianfagna, M. P. A. Ebert, J.-Y. Fang, C.-M. Gao, T. Gotze, F. Graziano, M. Lacasana-Navarro, et al. Meta- and Pooled Analyses of the Methylenetetrahydrofolate Reductase C677T and A1298C Polymorphisms and Gastric Cancer Risk: A Huge-GSEC Review Am. J. Epidemiol., March 1, 2008; 167(5): 505 - 516. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. Nilsson Is adiponectin and its genetic regulators useful or not for prediction of carotid intima-media thickness and coronary heart disease? Eur. Heart J., February 1, 2008; 29(3): 293 - 295. [Full Text] [PDF]
|
|
|
|
 |
|
 N. Krieger Proximal, Distal, and the Politics of Causation: What's Level Got to Do With It? Am J Public Health, February 1, 2008; 98(2): 221 - 230. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M Frayling Commentary: Genetic association studies see light at the end of the tunnel Int. J. Epidemiol., February 1, 2008; 37(1): 133 - 135. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Johansson, J. D. McKay, F. Wiklund, S. Rinaldi, M. Verheus, C. H. van Gils, G. Hallmans, K. Balter, H.-O. Adami, H. Gronberg, et al. Implications for Prostate Cancer of Insulin-Like Growth Factor-I (IGF-I) Genetic Variation and Circulating IGF-I Levels J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4820 - 4826. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Fraser, R. Harris, N. Sattar, S. Ebrahim, G. D. Smith, and D.A. Lawlor Gamma-Glutamyltransferase Is Associated With Incident Vascular Events Independently of Alcohol Intake: Analysis of the British Women's Heart and Health Study and Meta-Analysis Arterioscler. Thromb. Vasc. Biol., December 1, 2007; 27(12): 2729 - 2735. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Baker, T. Rahman, D. Hall, P. J Avery, B. M Mayosi, J. M C Connell, M. Farrall, H. Watkins, and B. Keavney The C-532T polymorphism of the angiotensinogen gene is associated with pulse pressure: A possible explanation for heterogeneity in genetic association studies of AGT and hypertension Int. J. Epidemiol., December 1, 2007; 36(6): 1356 - 1362. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Qi, N. Rifai, and F. B. Hu Interleukin-6 Receptor Gene Variations, Plasma Interleukin-6 Levels, and Type 2 Diabetes in U.S. Women Diabetes, December 1, 2007; 56(12): 3075 - 3081. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Crawley and G. Davey Smith Is chronic fatigue syndrome (CFS/ME) heritable in children, and if so, why does it matter? Arch. Dis. Child., December 1, 2007; 92(12): 1058 - 1061. [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. Vollset, J. Igland, M. Jenab, A. Fredriksen, K. Meyer, S. Eussen, H. K. Gjessing, P. M. Ueland, G. Pera, N. Sala, et al. The Association of Gastric Cancer Risk with Plasma Folate, Cobalamin, and Methylenetetrahydrofolate Reductase Polymorphisms in the European Prospective Investigation into Cancer and Nutrition Cancer Epidemiol. Biomarkers Prev., November 1, 2007; 16(11): 2416 - 2424. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Macleod Cannabis use and psychosis: the origins and implications of an association Advan. Psychiatr. Treat., November 1, 2007; 13(6): 400 - 411. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Associations of Plasma Fibrinogen Levels with Established Cardiovascular Disease Risk Factors, Inflammatory Markers, and Other Characteristics: Individual Participant Meta-Analysis of 154,211 Adults in 31 Prospective Studies: The Fibrinogen Studies Collaboration Am. J. Epidemiol., October 15, 2007; 166(8): 867 - 879. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. T. Higgins, J. Little, J. P. A. Ioannidis, M. S. Bray, T. A. Manolio, L. Smeeth, J. A. Sterne, B. Anagnostelis, A. S. Butterworth, J. Danesh, et al. Turning the Pump Handle: Evolving Methods for Integrating the Evidence on Gene-Disease Association Am. J. Epidemiol., October 15, 2007; 166(8): 863 - 866. [Full Text] [PDF]
|
|
|
|
|
|
M. Kivimaki, D. A. Lawlor, G. D. Smith, C. Eklund, M. Hurme, T. Lehtimaki, J. S. A. Viikari, and O. T. Raitakari Variants in the CRP Gene as a Measure of Lifelong Differences in Average C-Reactive Protein Levels: The Cardiovascular Risk in Young Finns Study, 1980 2001 Am. J. Epidemiol., October 1, 2007; 166(7): 760 - 764. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sanderson, G. Salanti, and J. Higgins Joint Effects of the N-Acetyltransferase 1 and 2 (NAT1 and NAT2) Genes and Smoking on Bladder Carcinogenesis: A Literature-based Systematic HuGE Review and Evidence Synthesis Am. J. Epidemiol., October 1, 2007; 166(7): 741 - 751. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Fewell, G. D. Smith, and J. A. C. Sterne Fewell et al. Respond to "Fuel for Debate" Am. J. Epidemiol., September 15, 2007; 166(6): 659 - 661. [Full Text] [PDF]
|
|
|
|
|
|
J. S. Elkins, S. C. Johnston, E. Ziv, D. Kado, J. A. Cauley, and K. Yaffe Methylenetetrahydrofolate Reductase C677T Polymorphism and Cognitive Function in Older Women Am. J. Epidemiol., September 15, 2007; 166(6): 672 - 678. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Dai, M. J Shrubsole, R. M Ness, D. Schlundt, Q. Cai, W. E Smalley, M. Li, Y. Shyr, and W. Zheng The relation of magnesium and calcium intakes and a genetic polymorphism in the magnesium transporter to colorectal neoplasia risk Am. J. Clinical Nutrition, September 1, 2007; 86(3): 743 - 751. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P A Ioannidis Genetic and molecular epidemiology J. Epidemiol. Community Health, September 1, 2007; 61(9): 757 - 758. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Heikkila, S. Ebrahim, and D. A Lawlor A systematic review of the association between circulating concentrations of C reactive protein and cancer J. Epidemiol. Community Health, September 1, 2007; 61(9): 824 - 833. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. D. Smith Capitalizing on Mendelian randomization to assess the effects of treatments J R Soc Med, September 1, 2007; 100(9): 432 - 435. [Full Text] [PDF]
|
|
|
|
|
|
C. Sacerdote, S. Guarrera, G. D. Smith, S. Grioni, V. Krogh, G. Masala, A. Mattiello, D. Palli, S. Panico, R. Tumino, et al. Lactase Persistence and Bitter Taste Response: Instrumental Variables and Mendelian Randomization in Epidemiologic Studies of Dietary Factors and Cancer Risk Am. J. Epidemiol., September 1, 2007; 166(5): 576 - 581. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Didelez and N. Sheehan Mendelian randomization as an instrumental variable approach to causal inference Statistical Methods in Medical Research, August 1, 2007; 16(4): 309 - 330. [Abstract] [PDF]
|
|
|
|
|
|
M. C Cornelis, A. El-Sohemy, and H. Campos Genetic polymorphism of the adenosine A2A receptor is associated with habitual caffeine consumption Am. J. Clinical Nutrition, July 1, 2007; 86(1): 240 - 244. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Gilbody, T. Lightfoot, and T. Sheldon Is low folate a risk factor for depression? A meta-analysis and exploration of heterogeneity J. Epidemiol. Community Health, July 1, 2007; 61(7): 631 - 637. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Ben-Shlomo Rising to the challenges and opportunities of life course epidemiology Int. J. Epidemiol., June 1, 2007; 36(3): 481 - 483. [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Hung, M. Hashibe, J. McKay, V. Gaborieau, N. Szeszenia-Dabrowska, D. Zaridze, J. Lissowska, P. Rudnai, E. Fabianova, I. Mates, et al. Folate-related genes and the risk of tobacco-related cancers in Central Europe Carcinogenesis, June 1, 2007; 28(6): 1334 - 1340. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Infante-Rivard, J. K. Vermunt, and C. R. Weinberg Excess Transmission of the NAD(P)H:Quinone Oxidoreductase 1 (NQO1) C609T Polymorphism in Families of Children with Acute Lymphoblastic Leukemia Am. J. Epidemiol., June 1, 2007; 165(11): 1248 - 1254. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Hubner, S. Lubbe, I. Chandler, and R. S. Houlston MTHFR C677T has differential influence on risk of MSI and MSS colorectal cancer Hum. Mol. Genet., May 1, 2007; 16(9): 1072 - 1077. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H Campbell and T Manolio Commentary: Rare alleles, modest genetic effects and the need for collaboration Int. J. Epidemiol., April 30, 2007; (2007) dym055v1. [Full Text] [PDF]
|
|
|
|
|
|
M. J Khoury, J. Little, M. Gwinn, and J. P. Ioannidis On the synthesis and interpretation of consistent but weak gene-disease associations in the era of genome-wide association studies Int. J. Epidemiol., April 1, 2007; 36(2): 439 - 445. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Lawlor, G. D. Smith, M. O'Callaghan, R. Alati, A. A. Mamun, G. M. Williams, and J. M. Najman Epidemiologic Evidence for the Fetal Overnutrition Hypothesis: Findings from the Mater-University Study of Pregnancy and Its Outcomes Am. J. Epidemiol., February 15, 2007; 165(4): 418 - 424. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A Lawlor, I. N M Day, T. R Gaunt, L. J Hinks, N. Timpson, S. Ebrahim, and G. Davey Smith The association of the paraoxonase (PON1) Q192R polymorphism with depression in older women: findings from the British Women's Heart and Health Study J. Epidemiol. Community Health, January 1, 2007; 61(1): 85 - 87. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Gilbody, S. Lewis, and T. Lightfoot Methylenetetrahydrofolate Reductase (MTHFR) Genetic Polymorphisms and Psychiatric Disorders: A HuGE Review Am. J. Epidemiol., January 1, 2007; 165(1): 1 - 13. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Abilleira, S. Bevan, and H. S Markus The role of genetic variants of matrix metalloproteinases in coronary and carotid atherosclerosis J. Med. Genet., December 1, 2006; 43(12): 897 - 901. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Lewis, R. M. Harbord, R. Harris, and G. D. Smith Meta-analyses of Observational and Genetic Association Studies of Folate Intakes or Levels and Breast Cancer Risk. J Natl Cancer Inst, November 15, 2006; 98(22): 1607 - 1622. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. J. Mukamal, S. E. Chiuve, and E. B. Rimm Alcohol consumption and risk for coronary heart disease in men with healthy lifestyles. Arch Intern Med, October 23, 2006; 166(19): 2145 - 2150. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Pezzini, M Grassi, E Del Zotto, D Assanelli, S Archetti, R Negrini, L Caimi, and A Padovani Interaction of homocysteine and conventional predisposing factors on risk of ischaemic stroke in young people: consistency in phenotype-disease analysis and genotype-disease analysis J. Neurol. Neurosurg. Psychiatry, October 1, 2006; 77(10): 1150 - 1156. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T-H Lu Unalterable host factors? A social epidemiologist's view of the Haddon matrix. Inj. Prev., October 1, 2006; 12(5): 285 - 286. [Full Text] [PDF]
|
|
|
|
 |
|
 H. S. Markus, R. Labrum, S. Bevan, M. Reindl, G. Egger, C. J. Wiedermann, Q. Xu, S. Kiechl, and J. Willeit Genetic and Acquired Inflammatory Conditions Are Synergistically Associated With Early Carotid Atherosclerosis Stroke, September 1, 2006; 37(9): 2253 - 2259. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. D. SMITH Mensuration, Mendel, and a 19th century public health justification for US imperialism Int. J. Epidemiol., August 1, 2006; 35(4): 811 - 813. [Full Text] [PDF]
|
|
|
|
|
|
J. P Casas, T. Shah, J. Cooper, E. Hawe, A. D McMahon, D. Gaffney, C. J Packard, D. S O'Reilly, I. Juhan-Vague, J. S Yudkin, et al. Insight into the nature of the CRP-coronary event association using Mendelian randomization Int. J. Epidemiol., August 1, 2006; 35(4): 922 - 931. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. L. N Husemoen, U. Toft, M. Fenger, T. Jorgensen, N. Johansen, and A. Linneberg The association between atopy and factors influencing folate metabolism: is low folate status causally related to the development of atopy? Int. J. Epidemiol., August 1, 2006; 35(4): 954 - 961. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. H. Bech, H. Autrup, E. A. Nohr, T. B. Henriksen, and J. Olsen Stillbirth and slow metabolizers of caffeine: comparison by genotypes Int. J. Epidemiol., August 1, 2006; 35(4): 948 - 953. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J Glynn Commentary: Genes as instruments for evaluation of markers and causes Int. J. Epidemiol., August 1, 2006; 35(4): 932 - 934. [Full Text] [PDF]
|
|
|
|
|
|
B. Keavney, J. Danesh, S. Parish, A. Palmer, S. Clark, L. Youngman, M. Delepine, M. Lathrop, R. Peto, R. Collins, et al. Fibrinogen and coronary heart disease: test of causality by 'Mendelian randomization' Int. J. Epidemiol., August 1, 2006; 35(4): 935 - 943. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Davey Smith, N. Timpson, and D. A. Lawlor C-Reactive Protein and Cardiovascular Disease Risk: Still an Unknown Quantity? Ann Intern Med, July 4, 2006; 145(1): 70 - 72. [Full Text] [PDF]
|
|
|
|
 |
|
 W. Li, M. Wang, P. Irigoyen, and P. K. Gregersen Inferring causal relationships among intermediate phenotypes and biomarkers: a case study of rheumatoid arthritis Bioinformatics, June 15, 2006; 22(12): 1503 - 1507. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. EBRAHIM The future of modern epidemiology: genetics, methods, and history Int. J. Epidemiol., June 1, 2006; 35(3): 511 - 512. [Full Text] [PDF]
|
|
|
|
|
|
J. Macleod and M. Hickman Commentary: Understanding pathways to cannabis use and from use to harm. Int. J. Epidemiol., June 1, 2006; 35(3): 680 - 682. [Full Text] [PDF]
|
|
|
|
|
|
|